Zixian Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zixian Chen has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Chen Cui
Department of Magnetic Resonance Imaging, Imaging Center, Fuwai Hospital,State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2 shared publications - Gang Yin
Department of Magnetic Resonance Imaging, Imaging Center, Fuwai Hospital,State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2 shared publications - Minjie Lu
Department of Magnetic Resonance Imaging, Fuwai Hospital and National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beilishi Road No. 167, Xicheng District, Beijing 100037
2 shared publications - Ni Liu
Department of Magnetic Resonance Imaging, Imaging Center, Fuwai Hospital,State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2 shared publications - Andrew E. Arai
Division of Cardiovascular Medicine and Department of Radiology, University of Utah School of Medicine, Salt Lake City, Utah
1 shared publication - Arlene Sirajuddin
Department of Health and Human Services, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md
1 shared publication
Latest Publications
- Open Access
- 7 November 2026
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- p. 1-14
Cardiovascular magnetic resonance feature-tracking strain characterization across phenotypic spectrum of danon disease
- 7 November 2026
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- p. 1-14
Open AccessCardiovascular magnetic resonance feature-tracking strain characterization across phenotypic spectrum of danon disease
- Open Access
- 3 June 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1749534
Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report
Immune checkpoint inhibitors (ICIs) are pivotal in treating advanced malignancies, including hepatocellular carcinoma (HCC). However, they can trigger immune-related adverse events (irAEs), among which myocarditis is one of the most life-threatening. Herein, we report the case of a 56-year-old man with HCC who developed myocarditis after receiving two cycles of the PD-1 inhibitor sintilimab. The diagnosis was established via cardiac magnetic resonance (CMR) and confirmed by endomyocardial biopsy (EMB). Following treatment with high-dose corticosteroids and supportive therapy, the patient's condition exhibited significant improvement.
- 3 June 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1749534
Open AccessImmune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report
Immune checkpoint inhibitors (ICIs) are pivotal in treating advanced malignancies, including hepatocellular carcinoma (HCC). However, they can trigger immune-related adverse events (irAEs), among which myocarditis is one of the most life-threatening. Herein, we report the case of a 56-year-old man with HCC who developed myocarditis after receiving two cycles of the PD-1 inhibitor sintilimab. The diagnosis was established via cardiac magnetic resonance (CMR) and confirmed by endomyocardial biopsy (EMB). Following treatment with high-dose corticosteroids and supportive therapy, the patient's condition exhibited significant improvement.
- 30 August 2025
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 63 (2) , 403-414
Sex‐Specific Cardiac Magnetic Resonance Phenotypes in Danon Disease: A Retrospective Cohort Study
Background: Danon disease (DD), an X‐linked disorder due to lysosome‐associated membrane protein 2 (LAMP2) mutations, features life‐threatening cardiomyopathy. Sex‐based cardiac magnetic resonance (cardiac MR) differences are recognized but lack quantitative analysis despite their critical importance in establishing sex‐specific diagnostic thresholds and personalized treatment strategies. Purpose: To investigate sex‐based differences in cardiac MR manifestations in DD. Study Type: Retrospective. Subjects: 24 DD patients (15 males, 9 females; January 2018–February 2025). Field Strength/Sequence: 3‐T, cine imaging (gradient‐echo sequence), late gadolinium enhancement (LGE) imaging (inversion‐recovery gradient‐echo sequence), T1 mapping (modified look‐locker inversion‐recovery gradient‐echo sequence), T2 mapping (gradient‐echo sequence with T2 preparation). Assessment: Standardized cardiac MR assessed structural indices (LV volumes/mass, wall thickness), functional metrics (EF, strain), and tissue characterization (late gadolinium enhancement [LGE extent, T1/T2 values]). Statistical Tests: Sex comparisons used independent t‐tests/Mann–Whitney U for continuous variables; Chi‐square/Fisher's exact for categorical variables. p < 0.05 significant. Results: Males predominantly developed hypertrophic cardiomyopathy (HCM: 73.3%), whereas females universally exhibited dilated cardiomyopathy (DCM: 88.9%) with preserved septal thickness. Ventricular arrhythmias occurred in all females (100% vs. 73.3% in males). Females showed significantly worse left ventricular ejection fraction (LVEF: 37.0% ± 14.0% vs. 49.9% ± 17.9%). Cardiac MR revealed extensive LGE (21.9% ± 11.4%, diffuse free‐wall involvement), elevated extracellular volume (ECV) (ECV: 38% ± 12%), and significantly prolonged T1/T2 values (1374 ± 60 ms/46.5 ± 5.4 ms; T1 was higher in females). Global longitudinal strain (GLS: −6.5% ± 4.0%), radial strain (GRS: 16.9% ± 12.2%), and circumferential strain (GCS: −10.6% ± 5.7% ) were reduced, with significantly worse systolic impairment in females. Data Conclusion: Sex‐specific cardiac MR patterns exist in DD: males predominantly develop HCM, whereas females primarily exhibit DCM, with apical/free wall LGE observed in both sexes, though mid‐basal septum sparing is more frequent in males. These findings enable sex‐stratified early diagnosis and phenotype‐tailored surveillance, guiding clinical management. Evidence Level: 4. Technical Efficacy: Stage 2.
- 30 August 2025
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 63 (2) , 403-414
Sex‐Specific Cardiac Magnetic Resonance Phenotypes in Danon Disease: A Retrospective Cohort Study
Background: Danon disease (DD), an X‐linked disorder due to lysosome‐associated membrane protein 2 (LAMP2) mutations, features life‐threatening cardiomyopathy. Sex‐based cardiac magnetic resonance (cardiac MR) differences are recognized but lack quantitative analysis despite their critical importance in establishing sex‐specific diagnostic thresholds and personalized treatment strategies. Purpose: To investigate sex‐based differences in cardiac MR manifestations in DD. Study Type: Retrospective. Subjects: 24 DD patients (15 males, 9 females; January 2018–February 2025). Field Strength/Sequence: 3‐T, cine imaging (gradient‐echo sequence), late gadolinium enhancement (LGE) imaging (inversion‐recovery gradient‐echo sequence), T1 mapping (modified look‐locker inversion‐recovery gradient‐echo sequence), T2 mapping (gradient‐echo sequence with T2 preparation). Assessment: Standardized cardiac MR assessed structural indices (LV volumes/mass, wall thickness), functional metrics (EF, strain), and tissue characterization (late gadolinium enhancement [LGE extent, T1/T2 values]). Statistical Tests: Sex comparisons used independent t‐tests/Mann–Whitney U for continuous variables; Chi‐square/Fisher's exact for categorical variables. p < 0.05 significant. Results: Males predominantly developed hypertrophic cardiomyopathy (HCM: 73.3%), whereas females universally exhibited dilated cardiomyopathy (DCM: 88.9%) with preserved septal thickness. Ventricular arrhythmias occurred in all females (100% vs. 73.3% in males). Females showed significantly worse left ventricular ejection fraction (LVEF: 37.0% ± 14.0% vs. 49.9% ± 17.9%). Cardiac MR revealed extensive LGE (21.9% ± 11.4%, diffuse free‐wall involvement), elevated extracellular volume (ECV) (ECV: 38% ± 12%), and significantly prolonged T1/T2 values (1374 ± 60 ms/46.5 ± 5.4 ms; T1 was higher in females). Global longitudinal strain (GLS: −6.5% ± 4.0%), radial strain (GRS: 16.9% ± 12.2%), and circumferential strain (GCS: −10.6% ± 5.7% ) were reduced, with significantly worse systolic impairment in females. Data Conclusion: Sex‐specific cardiac MR patterns exist in DD: males predominantly develop HCM, whereas females primarily exhibit DCM, with apical/free wall LGE observed in both sexes, though mid‐basal septum sparing is more frequent in males. These findings enable sex‐stratified early diagnosis and phenotype‐tailored surveillance, guiding clinical management. Evidence Level: 4. Technical Efficacy: Stage 2.
- 20 September 2024
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 61 (5) , 2033-2050
Application of Myocardial Salvage Index as a Clinical Endpoint: Assessment Methods and Future Prospects
In patients with acute myocardial infarction (AMI), traditional clinical endpoints used to assess drug efficacy and prognosis include infarct size (IS), incidence of heart failure, and mortality rates. Although these metrics are commonly employed to evaluate outcomes in AMI patients, their utility is limited in small‐scale studies. The introduction of the myocardial salvage index (MSI) reduces variability in assessments across multiple dimensions, thereby enhancing the sensitivity of outcome measures and reducing the required sample size. Moreover, MSI is increasingly utilized to evaluate drug efficacy, prognosis, and risk stratification in AMI patients. Although a variety of methodologies for measuring the MSI are currently available, the incorporation of these methods as clinical endpoints remains limited. In the clinical application of cardioprotective strategies, it is recommended that MSI be evaluated using late gadolinium enhancement measured along the endocardial surface length combined with IS in cardiac magnetic resonance. In dynamic single‐photon emission computed tomography, an assessment of MSI using methods based on abnormalities in myocardial wall thickening combined with perfusion anomalies is advocated. This review comprehensively outlines the principles, advantages, and limitations of different MSI assessment methods and discusses the prospects and challenges of MSI in cardiac protective therapies. Additionally, we summarize recommended strategies for employing MSI as a clinical surrogate endpoint in various clinical scenarios, providing direction for future clinical practice and research.Evidence Level: 5Technical Efficacy: Stage 4
- 20 September 2024
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 61 (5) , 2033-2050
Application of Myocardial Salvage Index as a Clinical Endpoint: Assessment Methods and Future Prospects
In patients with acute myocardial infarction (AMI), traditional clinical endpoints used to assess drug efficacy and prognosis include infarct size (IS), incidence of heart failure, and mortality rates. Although these metrics are commonly employed to evaluate outcomes in AMI patients, their utility is limited in small‐scale studies. The introduction of the myocardial salvage index (MSI) reduces variability in assessments across multiple dimensions, thereby enhancing the sensitivity of outcome measures and reducing the required sample size. Moreover, MSI is increasingly utilized to evaluate drug efficacy, prognosis, and risk stratification in AMI patients. Although a variety of methodologies for measuring the MSI are currently available, the incorporation of these methods as clinical endpoints remains limited. In the clinical application of cardioprotective strategies, it is recommended that MSI be evaluated using late gadolinium enhancement measured along the endocardial surface length combined with IS in cardiac magnetic resonance. In dynamic single‐photon emission computed tomography, an assessment of MSI using methods based on abnormalities in myocardial wall thickening combined with perfusion anomalies is advocated. This review comprehensively outlines the principles, advantages, and limitations of different MSI assessment methods and discusses the prospects and challenges of MSI in cardiac protective therapies. Additionally, we summarize recommended strategies for employing MSI as a clinical surrogate endpoint in various clinical scenarios, providing direction for future clinical practice and research.Evidence Level: 5Technical Efficacy: Stage 4
- 21 June 2024
- Published by Elsevier in Academic Radiology
- Vol. 31 (11) , 4352-4364
Prognostic Value of CT-Derived Myocardial Biomarkers: Extracellular Volume Fraction and Strain in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis
- 21 June 2024
- Published by Elsevier in Academic Radiology
- Vol. 31 (11) , 4352-4364
Prognostic Value of CT-Derived Myocardial Biomarkers: Extracellular Volume Fraction and Strain in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis
- Open Access
- 21 March 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1348750
Case Report: A left ventricular pseudoaneurysm detected by cardiac magnetic resonance more than 1 year after a percutaneous transluminal coronary intervention
Pseudoaneurysm is a rare but lethal complication of acute myocardial infarction. In this study, we present a unique case of a patient with left ventricular free wall rupture detected by cardiac magnetic resonance more than 1 year after a percutaneous transluminal coronary intervention.
- 21 March 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1348750
Open AccessCase Report: A left ventricular pseudoaneurysm detected by cardiac magnetic resonance more than 1 year after a percutaneous transluminal coronary intervention
Pseudoaneurysm is a rare but lethal complication of acute myocardial infarction. In this study, we present a unique case of a patient with left ventricular free wall rupture detected by cardiac magnetic resonance more than 1 year after a percutaneous transluminal coronary intervention.
- 1 March 2020
- Published by Elsevier in European Journal of Radiology
- Vol. 124, 108836
Aortic regurgitation is common in hypertrophic cardiomyopathy: An echocardiography and cardiovascular magnetic resonance study
- 1 March 2020
- Published by Elsevier in European Journal of Radiology
- Vol. 124, 108836
Aortic regurgitation is common in hypertrophic cardiomyopathy: An echocardiography and cardiovascular magnetic resonance study